IgniteData Raises Series A to Expand Clinical Trial Network

Read More »

August 14, 2025

Shilpa Medicare’s NorUDCA Makes History as First Approved NAFLD Therapy Worldwide

Read More »

August 14, 2025

Gameto Raises $44 Million Series C to Advance Fertility Treatments

Read More »

August 13, 2025

Novartis Ianalumab Trials Succeed in Sjögren’s Disease

Read More »

August 11, 2025

ObjectiveHealth Rebrands GI Select Site to Expand Trial Access

Read More »

August 8, 2025

Mass General Brigham Launches Two Cancer MRD Trials

Read More »

August 7, 2025

SeaStar Hits Enrollment Milestone in AKI SCD Trial

Read More »

August 6, 2025

Ethris Doses First Patient in Phase 2a Clinical Trial of Lead mRNA Candidate ETH47 for Asthma

Read More »

August 5, 2025

Raytone Biotech Doses First Patient in RTP-008 Eye Trial

Read More »

August 4, 2025

Mosaiq Aiplex Vasculitis Assay Now CE Mark Approved

Read More »

August 4, 2025

BioXcel Completes Phase 3 Trial for Acute Bipolar Agitation

Read More »

August 1, 2025

Panome Bio Multi-omics Laboratory Enhances Clinical Capabilities with CLIA Certification

Read More »

July 29, 2025